2006
Physical activity in a cohort of HIV-positive and HIV-negative injection drug users
Smit E, Crespo C, Semba R, Jaworowicz D, Vlahov D, Ricketts E, Ramirez-Marrero F, Tang A. Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care 2006, 18: 1040-1045. PMID: 17012097, DOI: 10.1080/09540120600580926.Peer-Reviewed Original ResearchConceptsInjection drug usersHIV-positive participantsHIV-positive injection drug usersInjection drug useHIV-negativeVigorous activityPhysical activityDrug usersDrug usePaffenbarger Physical Activity QuestionnaireRecent injection drug usersHIV-negative injection drug usersIntravenous Experience cohortActive antiretroviral therapyCohort of HIVHIV-negative participantsPhysical Activity QuestionnairePhysical activity levelsAntiretroviral therapyHIV infectionViral loadHIV treatmentActivity QuestionnaireAnthropometric measurementsEnergy expenditure
1998
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease
Sterling T, Moore R, Graham N, Astemborski J, Vlahov D, Chaisson R. Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease. AIDS 1998, 12: 1451-1457. PMID: 9727565, DOI: 10.1097/00002030-199812000-00006.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS-Related Opportunistic InfectionsAntibiotic ProphylaxisAntitubercular AgentsCD4 Lymphocyte CountCohort StudiesFemaleHumansMaleMiddle AgedMycobacterium avium ComplexMycobacterium avium-intracellulare InfectionMycobacterium tuberculosisProspective StudiesRisk FactorsSubstance Abuse, IntravenousTuberculosisConceptsM. tuberculosis infectionM. avium complex diseaseMycobacterium tuberculosis infectionDisseminated MACTuberculosis infectionExtrapulmonary tuberculosisDrug useLow CD4 cell levelsProspective observational cohort studyAdult HIV clinicIntravenous Experience cohortPrior opportunistic infectionsCD4 cell levelsObservational cohort studyLogistic regression analysisALIVE cohortAntibiotic prophylaxisMAC prophylaxisAntiretroviral therapyCD4 lymphocytesHIV clinicMAC diseaseActive tuberculosisCohort studyOpportunistic infections